Electroencephalography in Psychiatric Surgery: Past Use and Future Directions.


Journal

Stereotactic and functional neurosurgery
ISSN: 1423-0372
Titre abrégé: Stereotact Funct Neurosurg
Pays: Switzerland
ID NLM: 8902881

Informations de publication

Date de publication:
2019
Historique:
received: 06 11 2018
accepted: 08 05 2019
pubmed: 15 8 2019
medline: 12 2 2020
entrez: 15 8 2019
Statut: ppublish

Résumé

The last two decades have seen a re-emergence of surgery for intractable psychiatric disease, in large part due to increased use of deep brain stimulation. The development of more precise, image-guided, less invasive interventions has improved the safety of these procedures, even though the relative merits of modulation at various targets remain under investigation. With an increase in the number and type of interventions for modulating mood/anxiety circuits, the need for biomarkers to guide surgeries and predict treatment response is as critical as ever. Electroencephalography (EEG) has a long history in clinical neurology, cognitive neuroscience, and functional neurosurgery, but has limited prior usage in psychiatric surgery. MEDLINE, Embase, and Psyc-INFO searches on the use of EEG in guiding psychiatric surgery yielded 611 articles, which were screened for relevance and quality. We synthesized three important themes. First, considerable evidence supports EEG as a biomarker for response to various surgical and non-surgical therapies, but large-scale investigations are lacking. Second, intraoperative EEG is likely more valuable than surface EEG for guiding target selection, but comes at the cost of greater invasiveness. Finally, EEG may be a promising tool for objective functional feedback in developing "closed-loop" psychosurgeries, but more systematic investigations are required.

Identifiants

pubmed: 31412334
pii: 000500994
doi: 10.1159/000500994
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

141-152

Informations de copyright

© 2019 S. Karger AG, Basel.

Auteurs

Karim Mithani (K)

Sunnybrook Research Institute, Toronto, Ontario, Canada.
Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.

Ying Meng (Y)

Sunnybrook Research Institute, Toronto, Ontario, Canada.

Agessandro Abrahao (A)

Sunnybrook Research Institute, Toronto, Ontario, Canada.

Mirriam Mikhail (M)

Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.

Clement Hamani (C)

Sunnybrook Research Institute, Toronto, Ontario, Canada.

Peter Giacobbe (P)

Sunnybrook Research Institute, Toronto, Ontario, Canada.

Nir Lipsman (N)

Sunnybrook Research Institute, Toronto, Ontario, Canada, nir.lipsman@utoronto.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH